Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?

Area of Science:

• Endocrinology
• Metabolic Bone Disease
• Skeletal Biology

Background:

• Metabolic bone disease, including osteoporosis, is a significant public health issue characterized by net bone density loss.
• The elderly population shows a relationship between body weight components (muscle, fat) and bone health metrics.
• While associations between muscle, fat, and bone are known, their functional interactions and endocrine roles are under active investigation.

Purpose of the Study:

• To review recent research on the interactions between bone, muscle, and adipose tissue.
• To survey the roles of parathyroid hormone (PTH) and PTH-related peptide (PTHrP) in these interactions.
• To highlight novel pathways for anabolic drug discovery and osteoporosis therapy.

Main Methods:

• Review of recent scientific literature on muscle-bone and fat-bone interactions.
• Analysis of endocrine functions and cellular/molecular mechanisms linking these tissues.
• Survey of the roles of parathyroid hormone (PTH) and PTH-related peptide (PTHrP).

Main Results:

• Muscle and fat tissues, alongside bone, possess endocrine functions, influencing skeletal homeostasis.
• These tissues communicate with traditional hormone and nervous systems and secrete regulatory factors.
• Interactions between muscle, fat, and bone are critical throughout life, from growth to aging.

Conclusions:

• Understanding the endocrine crosstalk between muscle, fat, and bone is key to unraveling bone anabolism and catabolism.
• This knowledge opens avenues for discovering new anabolic drugs.
• Targeting these pathways may lead to more effective therapies for osteoporosis and related disorders.